Thc Biomed Intl Stock Net Income
| THCBF Stock | USD 0 0.00 0.00% |
Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of THC Biomed Intl, as well as the relationship between them.
THC Biomed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing THC Biomed's valuation are provided below:THC Biomed Intl does not today have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. THC |
THC Biomed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to THC Biomed's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of THC Biomed.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in THC Biomed on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding THC Biomed Intl or generate 0.0% return on investment in THC Biomed over 90 days. THC Biomed is related to or competes with Avant Brands, and Rapid Nutrition. THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada More
THC Biomed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure THC Biomed's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess THC Biomed Intl upside and downside potential and time the market with a certain degree of confidence.
THC Biomed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for THC Biomed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as THC Biomed's standard deviation. In reality, there are many statistical measures that can use THC Biomed historical prices to predict the future THC Biomed's volatility.THC Biomed Intl Backtested Returns
We have found three technical indicators for THC Biomed, which you can use to evaluate the volatility of the company. The entity owns a Beta (Systematic Risk) of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and THC Biomed are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
THC Biomed Intl has no correlation between past and present. Overlapping area represents the amount of predictability between THC Biomed time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of THC Biomed Intl price movement. The serial correlation of 0.0 indicates that just 0.0% of current THC Biomed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, THC Biomed Intl reported net income of (3.07 Million). This is 100.9% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.54% higher than that of the company.
THC Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses THC Biomed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of THC Biomed could also be used in its relative valuation, which is a method of valuing THC Biomed by comparing valuation metrics of similar companies.THC Biomed is currently under evaluation in net income category among its peers.
THC Fundamentals
| Return On Equity | -0.41 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | (1.56) % | |||
| Operating Margin | (1.83) % | |||
| Current Valuation | 6.56 M | |||
| Shares Outstanding | 163.96 M | |||
| Shares Owned By Insiders | 29.02 % | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 1.37 X | |||
| Revenue | 3.34 M | |||
| Gross Profit | (1.03 M) | |||
| EBITDA | (1.64 M) | |||
| Net Income | (3.07 M) | |||
| Cash And Equivalents | 1.16 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 858.43 K | |||
| Debt To Equity | 0.56 % | |||
| Current Ratio | 0.93 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (1.86 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 35 | |||
| Beta | 1.12 | |||
| Market Capitalization | 8.59 M | |||
| Total Asset | 14.75 M | |||
| Retained Earnings | (2.75 M) | |||
| Working Capital | (299 K) | |||
| Current Asset | 349 K | |||
| Current Liabilities | 648 K | |||
| Z Score | 6.0 | |||
| Net Asset | 14.75 M |
About THC Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze THC Biomed Intl's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of THC Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of THC Biomed Intl based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in THC Pink Sheet
THC Biomed financial ratios help investors to determine whether THC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in THC with respect to the benefits of owning THC Biomed security.